Jun 14, 2022 / NTS GMT
Keyur Parekh - Goldman Sachs Group, Inc., Research Division - Equity Analyst
Good evening, good morning, good afternoon, everyone, and thank you for joining us. My name is Keyur Parekh, and I cover Sanofi for Goldman Sachs. Dietmar, thank you so much for taking the time to join us in California. Unfortunately, I'm stuck in somewhat sunny London. So that's kind of the saving grace, but thank you again for making the trip. I appreciate it.
Dietmar, before we kind of go to Q&A, just (inaudible) of introduction for everybody listening in. Dietmar is the head of Global kind of Development and the Chief Medical Officer for Sanofi, having joined Sanofi about 2.5 years back.
Dietmar, I don't know if you want to make some opening comments on kind of your 2.5 years at Sanofi, how that's kind of progressed, the kind of changes you've made, what you see -- what excites you today before we get into specific stuff.
Dietmar P. Berger - Sanofi - Chief Medical Officer & Global Head of Development
Yes, Great. Thanks for having me, first of all, and this is
Sanofi SA at Goldman Sachs Global Healthcare Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers